Skip to main content

Table 3 Human papillomavirus (HPV) types in women ≤40 years by Indigenous status, n (%)

From: Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program

HPV type Non-Indigenous women
(n= 1494)
Indigenous women
(n= 655)
6 47 (3.1%) 13 (2.0%)
11 9 (0.6%) 6 (0.9%)
16a 141 (9.4%) 69 (10.5%)
18a 62 (4.1%) 25 (3.8%)
2 0 1 (0.2%)
31a 56 (3.7%) 22 (3.4%)
33a 31 (2.1%) 18 (2.7%)
35a 16 (1.1%) 14 (2.1%)
39a 58 (3.9%) 24 (3.7%)
40 16 (1.1%) 4 (0.6%)
42 61 (4.1%) 19 (2.9%)
45a 23 (1.5%) 15 (2.3%)
51a 94 (6.3%) 37 (5.6%)
52a 57 (3.8%) 36 (5.5%)
53 82 (5.5%) 34 (5.2%)
54 49 (3.3%) 24 (3.7%)
55 29 (1.9%) 8 (1.2%)
56a 39 (2.6%) 16 (2.4%)
58a 44 (2.9%) 20 (3.1%)
59a 39 (2.6%) 22 (3.4%)
61 56 (3.7%) 33 (5.0%)
62 65 (4.4%) 35 (5.3%)
64 1 (0.1%) 0
66 61 (4.1%) 23 (3.5%)
67 24 (1.6%) 8 (1.2%)
68a,b 13 (0.9%) 21 (3.2%)
69 1 (0.1%) 4 (0.6%)
70b 21 (1.4%) 28 (4.3%)
71b 1 (0.1%) 7 (1.1%)
72c 2 (0.1%) 7 (1.1%)
73 40 (2.7%) 21 (3.2%)
81b 20 (1.3%) 29 (4.4%)
82 (previously IS39) [29] 20 (1.4%) 10 (1.6%)
83 19 (1.3%) 15 (2.3%)
84 61 (4.1%) 19 (2.9%)
89 (previously CP6108) [29] 68 (4.6%) 31 (4.7%)
No type detectedb 879 (58.8%) 332 (50.6%)
Multiple 354 (23.7%) 180 (27.4%)
   16/18 185 (12.5%) 86 (13.1%)
   6/11/16/18 220 (14.7%) 102 (15.5%)
   16/18 only 44 (2.9%) 21 (3.2%)
   6/11/16/18 only 53 (3.5%) 26 (4.0%)
  1. aEstablished high-risk HPV type.
  2. bχ2 P < 0.001.
  3. cχ2 P = 0.002.